Contineum Therapeutics (CTNM) Leases (2023 - 2025)
Contineum Therapeutics (CTNM) has 3 years of Leases data on record, last reported at $4.8 million in Q3 2025.
- For Q3 2025, Leases changed N/A year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, changed N/A, while the annual FY2024 figure was $5.5 million, 660.36% up from the prior year.
- Leases reached $4.8 million in Q3 2025 per CTNM's latest filing, down from $5.0 million in the prior quarter.
- Across five years, Leases topped out at $5.5 million in Q4 2024 and bottomed at $231000.0 in Q2 2024.
- Average Leases over 3 years is $3.1 million, with a median of $4.8 million recorded in 2025.
- Peak YoY movement for Leases: surged 660.36% in 2024, then surged 2067.53% in 2025.
- A 3-year view of Leases shows it stood at $719000.0 in 2023, then soared by 660.36% to $5.5 million in 2024, then decreased by 12.68% to $4.8 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.8 million in Q3 2025, $5.0 million in Q2 2025, and $5.2 million in Q1 2025.